Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Within Patient, Placebo Controlled Trial to Assess the Efficacy of Juvista (Avotermin) in Conjunction With Scar Revision Surgery for the Improvement of Disfiguring Scars.

NCT00742443 is registered in ClinicalTrials.gov with Renovo as lead sponsor.

NCT NCT00742443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00742443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Within Patient, Placebo Controlled Trial to Assess the Efficacy of Juvista (Avotermin) in Conjunction With Scar Revision Surgery for the Improvement of Disfiguring Scars.
Lead sponsor
Renovo
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2008
Completion date
February 28, 2011
Enrollment
350 (estimated)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

cicatrix